JPY 184.0
(-1.08%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -548.58 Million JPY | -138.63% |
2022 | 1.42 Billion JPY | 13.07% |
2021 | 1.25 Billion JPY | 456.59% |
2020 | -352.21 Million JPY | 67.98% |
2019 | -1.1 Billion JPY | -24.31% |
2018 | -884.9 Million JPY | -5.13% |
2017 | -841.7 Million JPY | 15.36% |
2016 | -994.5 Million JPY | 17.14% |
2015 | -1.2 Billion JPY | -418.09% |
2014 | -231.65 Million JPY | 87.42% |
2013 | -1.84 Billion JPY | -1122.47% |
2012 | -150.59 Million JPY | 32.53% |
2011 | -223.2 Million JPY | 69.21% |
2010 | -725.02 Million JPY | 48.76% |
2009 | -1.41 Billion JPY | -36.81% |
2008 | -1.03 Billion JPY | -43.44% |
2007 | -721.01 Million JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 FY | -548.58 Million JPY | -138.63% |
2023 Q4 | -548.58 Million JPY | 10.18% |
2023 Q3 | -610.79 Million JPY | -139.38% |
2023 Q2 | 1.55 Billion JPY | 7.99% |
2023 Q1 | 1.43 Billion JPY | 1.15% |
2022 Q1 | 1.16 Billion JPY | -7.03% |
2022 FY | 1.42 Billion JPY | 13.07% |
2022 Q4 | 1.42 Billion JPY | 31.84% |
2022 Q3 | 1.07 Billion JPY | -12.29% |
2022 Q2 | 1.22 Billion JPY | 5.18% |
2021 FY | 1.25 Billion JPY | 456.59% |
2021 Q1 | -470.56 Million JPY | -33.6% |
2021 Q4 | 1.25 Billion JPY | 519.49% |
2021 Q3 | 202.74 Million JPY | -21.97% |
2021 Q2 | 259.82 Million JPY | 155.22% |
2020 Q1 | -328.6 Million JPY | 70.13% |
2020 Q2 | -1.7 Billion JPY | -419.97% |
2020 Q4 | -352.21 Million JPY | 77.17% |
2020 FY | -352.21 Million JPY | 67.98% |
2020 Q3 | -1.54 Billion JPY | 9.7% |
2019 FY | -1.1 Billion JPY | -24.31% |
2019 Q1 | -923.88 Million JPY | -4.4% |
2019 Q2 | -931.57 Million JPY | -0.83% |
2019 Q3 | -1.19 Billion JPY | -28.74% |
2019 Q4 | -1.1 Billion JPY | 8.28% |
2018 Q2 | -1.25 Billion JPY | -40.14% |
2018 Q4 | -884.9 Million JPY | 31.69% |
2018 FY | -884.9 Million JPY | -5.13% |
2018 Q1 | -897.44 Million JPY | -6.62% |
2018 Q3 | -1.29 Billion JPY | -3.0% |
2017 Q4 | -841.7 Million JPY | 5.52% |
2017 FY | -841.7 Million JPY | 15.36% |
2017 Q3 | -890.85 Million JPY | 14.36% |
2017 Q2 | -1.04 Billion JPY | 2.75% |
2017 Q1 | -1.06 Billion JPY | -7.56% |
2016 Q4 | -994.5 Million JPY | -57.74% |
2016 Q3 | -630.48 Million JPY | 15.19% |
2016 Q1 | -930.57 Million JPY | 22.46% |
2016 Q2 | -743.38 Million JPY | 20.12% |
2016 FY | -994.5 Million JPY | 17.14% |
2015 Q2 | -1.77 Billion JPY | -12.25% |
2015 Q1 | -1.57 Billion JPY | -581.09% |
2015 Q4 | -1.2 Billion JPY | 30.51% |
2015 Q3 | -1.72 Billion JPY | 2.47% |
2015 FY | -1.2 Billion JPY | -418.09% |
2014 Q2 | -1.07 Billion JPY | -3.81% |
2014 FY | -231.65 Million JPY | 87.42% |
2014 Q4 | -231.65 Million JPY | 51.74% |
2014 Q3 | -479.99 Million JPY | 55.22% |
2014 Q1 | -1.03 Billion JPY | 43.91% |
2013 Q2 | -3.17 Billion JPY | 9.89% |
2013 Q3 | -2.69 Billion JPY | 15.23% |
2013 Q4 | -1.84 Billion JPY | 31.66% |
2013 Q1 | -3.52 Billion JPY | -2241.89% |
2013 FY | -1.84 Billion JPY | -1122.47% |
2012 Q1 | -280.97 Million JPY | -25.88% |
2012 Q3 | -300.07 Million JPY | -127.98% |
2012 Q4 | -150.59 Million JPY | 49.81% |
2012 FY | -150.59 Million JPY | 32.53% |
2012 Q2 | -131.62 Million JPY | 53.16% |
2011 Q4 | -223.2 Million JPY | 49.6% |
2011 FY | -223.2 Million JPY | 69.21% |
2011 Q3 | -442.84 Million JPY | 2.7% |
2011 Q2 | -455.11 Million JPY | 30.15% |
2011 Q1 | -651.52 Million JPY | 10.14% |
2010 Q1 | -1.35 Billion JPY | 4.35% |
2010 FY | -725.02 Million JPY | 48.76% |
2010 Q3 | -901.53 Million JPY | 15.06% |
2010 Q4 | -725.02 Million JPY | 19.58% |
2010 Q2 | -1.06 Billion JPY | 21.58% |
2009 Q4 | -1.41 Billion JPY | -20.31% |
2009 Q3 | -1.17 Billion JPY | -33.35% |
2009 Q2 | -881.95 Million JPY | 0.86% |
2009 Q1 | -889.56 Million JPY | 13.99% |
2009 FY | -1.41 Billion JPY | -36.81% |
2008 Q4 | -1.03 Billion JPY | -25.7% |
2008 Q3 | -822.74 Million JPY | 4.71% |
2008 Q2 | -863.37 Million JPY | 0.0% |
2008 FY | -1.03 Billion JPY | -43.44% |
2007 FY | -721.01 Million JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 16.05 Billion JPY | 103.417% |
DNA Chip Research Inc. | -388.4 Million JPY | -41.241% |
Cosmo Bio Company,Limited | -2.8 Billion JPY | 80.45% |
H.U. Group Holdings, Inc. | 41.99 Billion JPY | 101.306% |
FALCO HOLDINGS Co., Ltd. | -9.24 Billion JPY | 94.068% |
BML, Inc. | -68.84 Billion JPY | 99.203% |
Human Metabolome Technologies, Inc. | -1.56 Billion JPY | 64.884% |